Results 241 to 250 of about 6,183 (280)
Some of the next articles are maybe not open access.

Effects of Promethazine and Midodrine on Orthostatic Tolerance

Aviation, Space, and Environmental Medicine, 2011
Astronauts experience both orthostatic hypotension and space motion sickness during re-entry. Midodrine, an alpha1-adrenergic agonist, is used to treat orthostatic hypotension. Promethazine, a histamine H1-receptor antagonist, is prescribed for space motion sickness. Many astronauts need both midodrine and promethazine.
Michael G. Ziegler   +3 more
openaire   +3 more sources

Effect of Midodrine in Non-azotemic Liver Cirrhosis Patients with Refractory or Recurrent Ascites

International Journal of Recent Surgical and Medical Sciences
To study the effectiveness of midodrine in treatment of refractory, recurrent ascites in nonazotemic liver cirrhosis patients. This is a facility-based open-label parallel design randomized controlled trial conducted at the Regional Institute of ...
Ajaygowda M S   +7 more
semanticscholar   +1 more source

Midodrine treatment in children with recurrent vasovagal syncope

Cardiology in the Young, 2021
AbstractBackground:Vasovagal syncope is the most common cause of syncope in childhood and its treatment is not at a satisfactory level yet. We aimed to investigate patients who were diagnosed with vasovagal syncope, did not benefit from conventional treatment, received midodrine treatment, and to evaluate their response to midodrine treatment.Methods ...
Denizhan Bagrul   +4 more
openaire   +3 more sources

Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis

European Journal of Gastroenterology and Hepathology
Background Vasodilatation and bacterial dislocation are the main contributors to the catastrophic events in patients with decompensated liver cirrhosis (DLC).
Maha Elsabaawy   +5 more
semanticscholar   +1 more source

Midodrine-Induced Nightmares in the Treatment of Orthostatic Hypotension: A Case Report.

The Senior Care Pharmacist, 2023
Background Midodrine was the first medication approved by the Food and Drug Administration (FDA) for the treatment of orthostatic hypotension. Pharmacologically, midodrine is a peripheral selective alpha-1-adrenergic agonist that can improve standing ...
Lara Tran, Michael R Brodeur
semanticscholar   +1 more source

Midodrine for severe orthostatic hypotension

Drug and Therapeutics Bulletin, 2016
Midodrine (Bramox—Brancaster Pharma Limited) was authorised in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) in March 2015 for “the treatment of severe orthostatic hypotension due to autonomic dysfunction in adults when corrective factors have been ruled out and other forms of treatment are inadequate”.1Previously, midodrine ...
openaire   +2 more sources

Midodrine for Intradialytic Hypotension.

Nephrology Nursing Journal : Journal of The American Nephrology Nurses Association
Intradialytic hypotension (IDH) is a common occurrence in hemodialysis. IDH occurs when there is a drop in blood pressure along with hypotensive symptoms.
David Xiao, Timothy Nguyen
semanticscholar   +1 more source

A Case Series and Review of Literature Describing the Use of Midodrine for Vasopressor Effects in Infants With Congenital Heart Disease.

Hospital Pharmacy
Midodrine is an oral vasopressor option that allows for discontinuation of intravenous vasopressors for patients with cardiovascular conditions. It does not have a US Food and Drug Administration-labeled indication for use in children, and there is a ...
Taylor D Zelnicek   +3 more
semanticscholar   +1 more source

Effects of 30-Day Midodrine Administration, Compared to Placebo, on Blood Pressure, Cerebral Blood Flow Velocity, and Cognitive Performance in Persons with SCI.

Topics in Spinal Cord Injury Rehabilitation
Background Individuals with spinal cord injury (SCI) at and above T6 experience impaired descending cortical control of the autonomic nervous system, which predisposes them to blood pressure (BP) disorders including persistent hypotension.
Caitlyn G. Peters   +5 more
semanticscholar   +1 more source

Abstract 4137484: Clinical implications of combined midodrine and pulmonary vasodilator therapy in Portopulmonary Hypertension

Circulation
Introduction: Portopulmonary hypertension (POPH) and associated pulmonary vascular resistance (PVR) elevation is seen in the context of underlying portal hypertension and liver disease.
Nicholas Bergeron   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy